Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 bieling2018personalized
%A Bieling, M
%A Tischer, S
%A Kalinke, U
%A Blasczyk, R
%A Buus, S
%A Maecker-Kolhoff, B
%A Eiz-Vesper, B
%D 2018
%E Oncotarget,
%J Oncotarget
%K kalinke
%N 4
%P 4737-4757
%T Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes
%V 9
@article{bieling2018personalized,
added-at = {2018-02-28T13:55:28.000+0100},
author = {Bieling, M and Tischer, S and Kalinke, U and Blasczyk, R and Buus, S and Maecker-Kolhoff, B and Eiz-Vesper, B},
biburl = {https://www.bibsonomy.org/bibtex/24a8ced943d340f541b2983d5e2b88adc/kalinke},
editor = {Oncotarget},
interhash = {d1bdb68fa62e028a34ce28fc95ad29e5},
intrahash = {4a8ced943d340f541b2983d5e2b88adc},
journal = {Oncotarget},
keywords = {kalinke},
number = 4,
pages = {4737-4757},
pubmedurl = {https://www.ncbi.nlm.nih.gov/pubmed/29435138},
timestamp = {2018-09-18T14:33:20.000+0200},
title = {Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes},
volume = 9,
year = 2018
}